⌘K

Login Start Free

Home/Filings/4/0001144204-18-004008

4//SEC Filing

PRYWATA MICHAL 4

Accession 0001144204-18-004008

CIK 0001508381other

View on SEC.gov Company Profile

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 3:52 PM ET

Size

5.5 KB

Accession

0001144204-18-004008

Insider Transaction Report

Form 4

Period: 2018-01-24

Bionik Laboratories Corp.BNKL

DirectorChief Operating Officer10% Owner

Transactions

Award
Employee Stock Option (right to buy)
2018-01-24+500,000→ 500,000 total
Exercise: $0.15Exp: 2028-01-24→ Common Stock, par value $0.001 (500,000 underlying)

Footnotes (1)

[F1]The options vest 166,667 on January 24, 2019, 166,667 on January 24, 2020 and 166,666 on January 24, 2021.

Documents

1 file

4
tv484160_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Bionik Laboratories Corp.

CIK 0001508381

Entity typeother

Related Parties

1

filerCIK 0001635158

Filing Metadata

Form type: 4
Filed: Jan 25, 7:00 PM ET
Accepted: Jan 26, 3:52 PM ET
Size: 5.5 KB

View on SEC.gov